Skip to main content
Figure 2 | Journal of Nanobiotechnology

Figure 2

From: Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model

Figure 2

Release profile of albendazole from albumin nanoparticles. In-vitro release behaviour of ABZ from nanoparticle formulations BSA-ABZ 10 nm and Nab-ABZ 200 nm in PBS at pH 7.4. The nanoparticle dispersion was placed in an orbital shaker and shaken at 100 rpm at 37°C for 192 hours. The released ABZ concentration was measured by HPLC. Data are presented as mean ± SD (n = 2).

Back to article page